Le Lézard
Classified in: Business, Covid-19 virus
Subjects: ECO, REL, POL, AVO

C12 invited to discuss COVID-19 and positive economic outlook at the White House


SAN ANTONIO, Oct. 1, 2020 /PRNewswire/ -- On September 21st, seven C12 CEO members representing diverse industries and workforce contexts met with top economic advisors and policy-makers at the White House. These CEOs were invited to share their perspectives and concerns regarding the country's post-COVID-19 recovery strategy and to help shape the policies that will affect all Americans over the next 6-12 months. Topics of conversation included bolstering the economy, supporting American jobs, production of the vaccine, and continuing to safely re-open the American economy.

"It was both an honor and a humbling experience to meet face-to-face with the top leaders of our country and discuss perhaps the most critical issue of our generation," said Dave Taylor, CEO of PASLIN and C12 Member. "It was apparent to me that these leaders feel real pain for the losses incurred as a result of the coronavirus, are tirelessly working around the clock to defeat the virus and are doing everything in their power to protect the American people. This experience has strengthened my resolve to pray for and support our country's leaders so that America can lead the way to heal the rest of the world."

C12 was invited to the White House as a prominent voice of American businesses operating with both excellence and strong values for people and communities. The organization encourages leaders to steward their civic responsibility by engaging with our government, advocating on behalf of others, and leaning into uncertainty.

"The White House's pandemic response and recovery efforts impact millions of people. Regardless of person or political party preferences, business leaders have perspective, influence, and a responsibility to care for the people we lead. I'm grateful the COVID Task Force policy team is pursuing voices from the marketplace, and it is a privilege for CEOs from across C12 to be those voices," said Mike Sharrow, CEO of the C12 Group.

Representing more than 2,600 Members and over 700,000 employees of C12 companies, these CEOs embodied stewardship with dignity, compassion, and boldness.

About C12
C12 Group is the largest network of Christian CEOs and executives working together to increase company performance, integrate faith and business, and achieve excellence through the power of peers. Founded in 1992, C12 has become the trusted authority on incorporating business best practices with the foundation of Biblical principles and core values. Groups of faith-driven, results-minded CEOs and executives meet monthly to encourage and challenge one another to make better decisions, avoid costly mistakes, and create solid plans for business growth, all while striving to create eternal impact far beyond the bottom line.

Contact: Kevin Miller, C12 Group
(210) 767-6200
[email protected]

SOURCE The C12 Group LLC


These press releases may also interest you

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...



News published on and distributed by: